{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:40:44Z","timestamp":1786984844778,"version":"build-2736575974"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000867","name":"Robert Wood Johnson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000867","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000965","name":"American Federation for Aging Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000965","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006985","name":"Ischemia Research and Education Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006985","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["R01 HL-079235"],"award-info":[{"award-number":["R01 HL-079235"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013899","name":"M.S.I. Foundation","doi-asserted-by":"publisher","award":["5R01AG027002-06"],"award-info":[{"award-number":["5R01AG027002-06"]}],"id":[{"id":"10.13039\/100013899","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013899","name":"M.S.I. Foundation","doi-asserted-by":"publisher","award":["R01 AG034853-04"],"award-info":[{"award-number":["R01 AG034853-04"]}],"id":[{"id":"10.13039\/100013899","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013899","name":"M.S.I. Foundation","doi-asserted-by":"publisher","award":["5R01DK087961-02"],"award-info":[{"award-number":["5R01DK087961-02"]}],"id":[{"id":"10.13039\/100013899","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006734","name":"Princeton University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006734","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.atherosclerosis.2017.05.021","type":"journal-article","created":{"date-parts":[[2017,5,19]],"date-time":"2017-05-19T00:16:05Z","timestamp":1495152965000},"page":"68-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Associations of tumor necrosis factor alpha receptor type 1 with kidney function decline, cardiovascular events, and mortality risk in persons with coronary artery disease: Data from the Heart and Soul Study"],"prefix":"10.1016","volume":"263","author":[{"given":"Meyeon","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Maristany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Shlipak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Whooley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2017.05.021_bib1","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1359-6101(96)00026-3","article-title":"The potential biological and clinical significance of the soluble tumor necrosis factor receptors","volume":"7","author":"Aderka","year":"1996","journal-title":"Cytokine & Growth Factor Rev."},{"key":"10.1016\/j.atherosclerosis.2017.05.021_bib2","first-page":"863","article-title":"Tumor necrosis factor-\u03b1 receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction","volume":"111","author":"Valgimigli","year":"2005","journal-title":"Cytokine-Activation Long-Term Prognosis Myocard. Infarct. (C-ALPHA) Study"},{"key":"10.1016\/j.atherosclerosis.2017.05.021_bib3","first-page":"1486","article-title":"Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction","volume":"107","author":"Vasan","year":"2003","journal-title":"Fram. Heart Study"},{"key":"10.1016\/j.atherosclerosis.2017.05.021_bib4","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/318665a0","article-title":"Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon","volume":"318","author":"Aggarwal","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2017.05.021_bib5","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ki.2014.330","article-title":"Krolewski AS and Niewczas MA. Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes","volume":"87","author":"Pavkov","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.atherosclerosis.2017.05.021_bib6","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ki.2015.278","article-title":"Tumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes","volume":"89","author":"Pavkov","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.atherosclerosis.2017.05.021_bib7","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.2011060627","article-title":"Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes","volume":"23","author":"Niewczas","year":"2012","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2017.05.021_bib8","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1001\/jama.2008.711","article-title":"Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease","volume":"300","author":"Whooley","year":"2008","journal-title":"Jama"},{"key":"10.1016\/j.atherosclerosis.2017.05.021_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00365519950185940","article-title":"Evaluation of the dade behring N Latex cystatin C assay on the dade behring nephelometer II system","volume":"59","author":"Erlandsen","year":"1999","journal-title":"Scand. J. Clin. Lab. Invest"},{"key":"10.1016\/j.atherosclerosis.2017.05.021_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2017.05.021_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"139","author":"Levey","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2017.05.021_bib12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.ajkd.2013.01.012","article-title":"Trajectories of kidney function decline in young black and white adults with preserved GFR: results from the Coronary Artery Risk Development in Young Adults (CARDIA) study","volume":"62","author":"Peralta","year":"2013","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.atherosclerosis.2017.05.021_bib13","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1161\/01.CIR.0000100560.46946.EA","volume":"108","author":"Luepker","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2017.05.021_bib14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/jama.297.2.169","article-title":"N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease","volume":"297","author":"Bibbins-Domingo","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2017.05.021_bib15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/jama.297.2.169","article-title":"N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease","volume":"297","author":"Bibbins-Domingo","year":"2007","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2017.05.021_bib16","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.atherosclerosis.2014.09.005","article-title":"Soluble tumor necrosis factor receptor 1 (sTNFR1) is associated with increased total mortality due to cancer and cardiovascular causes - findings from two community based cohorts of elderly","volume":"237","author":"Carlsson","year":"2014","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2017.05.021_bib17","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.2215\/CJN.13121215","article-title":"Raj DS and investigators tCS. Inflammation and progression of CKD: the CRIC study","volume":"11","author":"Amdur","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2017.05.021_bib18","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N.\u00a0Engl. J. Med."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017302241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017302241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:36:38Z","timestamp":1758155798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915017302241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":18,"alternative-id":["S0021915017302241"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.05.021","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations of tumor necrosis factor alpha receptor type 1 with kidney function decline, cardiovascular events, and mortality risk in persons with coronary artery disease: Data from the Heart and Soul Study","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}